China has taken new measures to ensure the quality of medical supplies exports amid the global fight against the novel coronavirus disease (COVID-19), authorities said.
The pharma industry (IPI) earns around 70 per cent of its revenues from sale of generic drugs and generates around 50 per cent of its revenues from exports